8:30 AM - 54-01 - Aquatic Exposure Assessment of Human Pharmaceuticals in European River Basins using GREAT-ER.
Webb, S.^*,1, Schowanek, D.¹, ¹ Procter & Gamble Eurocor, Strombeek-Bever, Belgium

FULL ABSTRACT

9:00 AM - 54-02 - Occurrence and identification of pharmaceuticals in the aquatic environment.
Heberer, Thomas^*,1, ¹ TU Berlin, Berlin, Germany

FULL ABSTRACT

9:30 AM - 54-03 - The fate and effects of antibacterial compounds in the environment.
Boxall, A.^*,1, Blackwell, P.¹, Boleas, S.², Sorensen, B.³, Kay, P.¹, Montforts, M.⁴, Schmitt, H.^4,5, Tarazona, J.², Tolls, J.⁵, ¹ Cranfield Centre for EcoChemistry, Shardlow, United Kingdom² INIA, Madrid, Spain³ Royal Danish School of Pharmacy, Copenhagen, Denmark⁴ RIVM, Bilthoven, Netherlands⁵ IRAS, University of Utrecht, Utrecht, Netherlands

FULL ABSTRACT

10:30 AM - 54-04 - Reproductive and developmental effects of endocrine disrupters in invertebrates: in vitro and in vivo approaches.
Hutchinson, Tom^*,1, ¹ AstraZeneca Global Safety, Health & Environment, Brixham, UK

FULL ABSTRACT

11:00 AM - 54-05 - Environmental Risk Assessment of Pharmaceutical Drug Substances - Conceptual Considerations.
Laenge, Reinhard^*,1, Dietrich, Daniel², ¹ Schering AG, Berlin, Germany² University of Konstanz, Konstanz, Germany

FULL ABSTRACT

11:30 AM - 54-06 - Linking product assessment to environmental policy making: medicines and feed additives.
Montforts, Mark^*,1, ¹ RIVM P.O. box 1, Bilthoven, Netherlands

FULL ABSTRACT